Trial Profile
A Pilot Study to Evaluate the Safety and Tolerability of the combination ot Trabectidin and Indole-3-Carbinol in refractory ER-positive metastatic breast cancer [Studio pilota per valutare la sicurezza e la tollerabilita' della combinazione Trabectidina e Indolo-3-Carbinolo nel tumore metastatico della mammella,refrattario ER-positivo]
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2014
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary) ; Indole-3-carbinol
- Indications Breast cancer
- Focus Adverse reactions
- Sponsors PharmaMar
- 30 May 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
- 26 Feb 2014 New trial record